Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease

Anemia, Sickle Cell [complications]Anticoagulants [therapeutic use]Heparin, Low-Molecular-Weight [therapeutic use]Peripheral Vascular Diseases [drug therapyetiology]Randomized Controlled Trials as Topic Humans